Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

  • V Saraswat
  • , S Norris
  • , Rob de Knegt
  • , JF Sanchez Avila
  • , M Sonderup
  • , E Zuckerman
  • , P Arkkila
  • , C Stedman
  • , S Acharya
  • , I Aho
  • , AC Anand
  • , MI Andersson
  • , V Arendt
  • , O Baatarkhuu
  • , K Barclay
  • , Z Ben-Ari
  • , C Bergin
  • , F Bessone
  • , S Blach
  • , N Blokhina
  • CR Brunton, G Choudhuri, V Chulanov, L Cisneros, EA (Esther) Croes, YA Dahgwahdorj, O Dalgard, JR Daruich, NR Dashdorj, D Davaadorj, M de Vree, C Estes, R Flisiak, AC Gadano, E Gane, W Halota, A Hatzakis, C Henderson, P Hoffmann, J Hornell, D Houlihan, S Hrusovsky, P Jarcuska, D Kershenobich, K Kostrzewska, P Kristian, M Leshno, Y Lurie, A Mahomed, N Mamonova, N Mendez-Sanchez, J Mossong, E Nurmukhametova, P Nymadawa, M Oltman, J Oyunbileg, T Oyunsuren, G Papatheodoridis, N Pimenov, N Prabdial-Sing, M Prins, P Puri, S Radke, A Rakhmanova, H Razavi, K Razavi-Shearer, HW Reesink, E Ridruejo, R Safadi, O Sagalova, R Sanduijav, I Schreter, C Seguin-Devaux, SR Shah, I Shestakova, A Shevaldin, O Shibolet, S Sokolov, K Souliotis, CW Spearman, T Staub, EA Strebkova, D Struck, K Tomasiewicz, L Undram, Adriaan van der Meer, D van Santen, I Veldhuijzen, FG Villamil, S Willemse, FR Zuure, MO Silva, V Sypsa, E Gower

Research output: Contribution to journalArticleAcademicpeer-review

90 Citations (Scopus)

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8666000 cases) and Russia (4162000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.
Original languageUndefined/Unknown
Pages (from-to)6-25
Number of pages20
JournalJournal of Viral Hepatitis
Volume22
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-04-20-01

Cite this